Nextech Invest logo

Nextech Invest

Crunchbase
Pitchbook
Crunchbase

Deals on record

5

Common Fundraising Type

Series C

Be Bio logo
Be Bio

Engineered B Cell Medicines • Therapeutic proteins

Nextech logo
Takeda Ventures logo
RA Capital Management logo
Longwood Fund logo

Be Biopharma is developing engineered B cell medicines to produce therapeutic proteins for treating conditions like Hemophilia B and Hypophosphatasia.

Series C
$92M
01/15/2025
Article
Alpha-9 Oncology logo
Alpha-9 Oncology

Radiopharmaceuticals • Clinical-stage

Ascenta Capital logo
Lightspeed Venture Partners logo
Samsara BioCapital logo
RA Capital Management logo

Alpha-9 Oncology Inc. develops targeted radiopharmaceuticals to improve cancer treatment.

Series C
$175M
10/23/2024
Article
Circle Pharma logo
Circle Pharma

Biopharmaceutical • Clinical development

The Column Group logo
Nextech Invest logo
Euclidean Capital logo

Circle Pharma is a biopharmaceutical company developing cell-permeable macrocycle treatments for cancer and other serious diseases.

Series D
$90M
09/03/2024
Article
Atavistik Bio logo
Atavistik Bio

Biotech • Precision Allosteric Therapeutics

The Column Group logo
Nextech Invest logo
Lux Capital logo

Atavistik Bio is a biotech company developing precision allosteric therapeutics for oncology, leveraging proprietary screening technology and AI to discover new treatment sites on proteins or RNA.

Equity
$40M
12/19/2023
Article
Mariana Oncology logo
Mariana Oncology

Biotechnology • Oncology

Forbion logo
Deep Track Capital logo
Surveyor Capital logo
RA Capital Management logo

Mariana Oncology is a biotechnology company that develops targeted peptide-based radiopharmaceuticals for the treatment of cancer, with a focus on delivering optimized radiation doses to solid tumors.

Series B
$175M
09/07/2023
Article